Comparison Chart Lineage Cell Therapeutics, Inc.
Stocks
LCTX
US53566P1093
Biotechnology & Medical Research
|
Market Closed -
NYSE
04:00:00 31/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1.000 USD | -2.91% |
|
0.00% | -40.12% |
| 10-29 | Lineage Cell Therapeutics Provides Update On ReSonance Program For Hearing Loss | CI |
| 10-01 | EARNINGS: Generation Essentials interim profit jumps to USD28 million | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -2.91% | 0.00% | -40.12% | -45.65% | -56.14% | 253M |  |  | |
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
